VA seeks lab for MRD detection in hematologic cancers, SDVOSB set-aside.
The Department of Veterans Affairs, Network Contract Office 20, is soliciting a long-term contract for a specialized reference laboratory to provide measurable residual disease (MRD) detection services for hematologic malignancies. The contract includes a base period plus four option years, running from September 1, 2026, to August 31, 2031. The laboratory must be CLIA-certified and capable of performing MRD testing using flow cytometry, PCR, or NGS methods. The VA serves veterans across the Pacific Northwest region, and the contractor must support multiple VA medical centers. The solicitation is set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB).